93 related articles for article (PubMed ID: 25958051)
1. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP2C9 in a Chinese Tibetan population.
Jin T; Geng T; He N; Shi X; Wang L; Yuan D; Kang L
Gene; 2015 Aug; 567(2):196-200. PubMed ID: 25958051
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of drug metabolizing phase-I enzymes CYP3A4 in Tibetan populations.
Liu L; Chang Y; Du S; Shi X; Yang H; Kang L; Jin T; Yuan D; He Y
J Genet; 2017 Jun; 96(2):219-225. PubMed ID: 28674221
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C
Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254
[TBL] [Abstract][Full Text] [Related]
4. Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.
Yan W; Wang YW; Yang FF; Wang M; Zhang XQ; Dong J; Chen E; Yang J
Genet Mol Res; 2013 Dec; 12(4):6454-61. PubMed ID: 24390994
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms analysis of drug-metabolizing enzyme CYP2C9 in the Uyghur population.
Jin T; Xun X; Du S; Geng T; Wang H; Feng T; Chen C; Yuan D; Kang L
Xenobiotica; 2016 Aug; 46(8):709-14. PubMed ID: 26610168
[TBL] [Abstract][Full Text] [Related]
6. High allele frequency of CYP2C9*3 (rs1057910) in a Negrito's subtribe population in Malaysia; Aboriginal people of Jahai.
Rosdi RA; Mohd Yusoff N; Ismail R; Soo Choon T; Saleem M; Musa N; Yusoff S
Ann Hum Biol; 2016 Sep; 43(5):445-50. PubMed ID: 26402341
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.
Cao P; Zhao Q; Shao Y; Yang H; Jin T; Li B; Li H
Medicine (Baltimore); 2018 Oct; 97(40):e12579. PubMed ID: 30290621
[TBL] [Abstract][Full Text] [Related]
8. Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.
Jin T; Zhang X; Geng T; Shi X; Wang L; Yuan D; Kang L
Mol Med Rep; 2016 Mar; 13(3):2117-23. PubMed ID: 26781306
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 2A6 in a Tibetan Chinese population.
Xia R; Zhu X; Chen Z; He Y; Kang L; Yuan D; Jin T; Wang L
Int J Clin Exp Pathol; 2018; 11(10):5024-5033. PubMed ID: 31949579
[TBL] [Abstract][Full Text] [Related]
10. Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.
Zhu BF; Wang HD; Shen CM; Deng YJ; Yang G; Wu QJ; Xu P; Qin HX; Fan SL; Huang P; Deng LB; Lucas R; Wang ZY
Hum Immunol; 2010 Nov; 71(11):1116-23. PubMed ID: 20650299
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.
Ding Y; Yang D; Zhou L; He P; Yao J; Xie P; Lin D; Sun D; Sun P; Li Q; Geng T; Jin T
Int J Clin Exp Med; 2015; 8(11):21024-33. PubMed ID: 26885033
[TBL] [Abstract][Full Text] [Related]
12. Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations.
Teh LK; Subramaniam V; Tuan Abdu Aziz TA; Lee LS; Ismail MI; Yu CY; Ang GY; James Johari R; Ismet RI; Sahak NS; Ahmad A; Rahman TA; Nor Ghazali FM; Shaari S; Omar M; Ismail AI; Md Isa K; Salleh H; Salleh MZ
Drug Metab Pharmacokinet; 2016 Aug; 31(4):304-13. PubMed ID: 27325019
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in drug-metabolizing enzyme CYP2C9 among major ethnic groups of Pakistani population.
Hizbullah ; Ahmed S; Noor Mumtaz M; Zulfiqar Z; Amir Hamza S; Siraj S; Jelani M; Imran I; Khan A
Gene; 2020 Jul; 746():144659. PubMed ID: 32276000
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic analysis of CYP2C9 gene in Vietnamese population.
Vu NP; Ma TTH; Tran NTB; Huynh HTT; Nguyen TD; Nguyen DT; Van Nong H; Lee MTM; Nguyen HH
Mol Biol Rep; 2018 Oct; 45(5):893-900. PubMed ID: 29978384
[TBL] [Abstract][Full Text] [Related]
15. A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.
Xiong Y; Wang M; Fang K; Xing Q; Feng G; Shen L; He L; Qin S
Genomics; 2011 May; 97(5):277-81. PubMed ID: 21126569
[TBL] [Abstract][Full Text] [Related]
16. Distributive characteristics of the CYP2C9 and AGTR1 genetic polymorphisms in Han Chinese hypertensive patients: a retrospective study.
Chen K; Xiao P; Li G; Wang C; Yang C
BMC Cardiovasc Disord; 2021 Feb; 21(1):73. PubMed ID: 33541272
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.
Zhang X; Meng X; Wang Y; Yan W; Yang J
Biochem Genet; 2012 Dec; 50(11-12):967-77. PubMed ID: 22983686
[TBL] [Abstract][Full Text] [Related]
18. Frequency distribution of single nucleotide polymorphisms in P-selectin gene in Chinese Tibetan and Han populations.
Zeng TT; Ye YX; Niu Q; Lu XJ; An YF; Li XP; Jiang H
Gene; 2012 May; 499(2):352-6. PubMed ID: 22425972
[TBL] [Abstract][Full Text] [Related]
19. Ethnic differences in CYP2C9*2 (Arg144Cys) and CYP2C9*3 (Ile359Leu) genotypes in Japanese and Israeli populations.
Nakai K; Habano W; Nakai K; Fukushima N; Suwabe A; Moriya S; Osano K; Gurwitz D
Life Sci; 2005 Nov; 78(1):107-11. PubMed ID: 16111713
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the major cytochrome P450 1A2 genetic variant in a healthy Tibetan population in China.
Ren Y; Liu F; Shi X; Geng T; Yuan D; Wang L; Kang L; Jin T; Chen C
Mol Med Rep; 2017 Jul; 16(1):573-580. PubMed ID: 28560456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
